We and other investigators have previously reported that MR increased TNF-related apoptosis-induced ligand receptor-2 (TRAIL-R2) expression in cancer cells and enhanced the efficacy of TRAIL-R2 targeted therapy (Strekalova et al., 2015; Yamamoto et al., 2020b). This evidence concerns the gene NR3C2 and cancer.